Net Assets for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported net assets is $26.54B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingNet AssetsSwitch metric
Latest period
$26.54B
YoY change
+87.0%
5Y CAGR
+36.3%
Peak year (2025)
$26.54B
Latest annual
$26.54B
Net Assets history chart for Eli Lilly (LLY) from 1985 to 2025
Net Assets history table for Eli Lilly (LLY) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $26.54B | +87.0% | ||
| 2024 | $14.19B | +31.8% | ||
| 2023 | $10.77B | +1.1% | ||
| 2022 | $10.65B | +18.6% | ||
| 2021 | $8.98B | +59.2% | ||
| 2020 | $5.64B | +116.4% | ||
| 2019 | $2.61B | -73.5% | ||
| 2018 | $9.83B | -15.2% | ||
| 2017 | $11.59B | -17.2% | ||
| 2016 | $14.01B | -3.9% | ||
| 2015 | $14.57B | -5.2% | ||
| 2014 | $15.37B | -12.8% | ||
| 2013 | $17.63B | +19.4% | ||
| 2012 | $14.77B | +9.0% | ||
| 2011 | $13.54B | +9.0% | ||
| 2010 | $12.42B | +30.4% | ||
| 2009 | $9.52B | +41.4% | ||
| 2008 | $6.74B | -50.1% | ||
| 2007 | $13.50B | +23.0% | ||
| 2006 | $10.98B | +1.7% | ||
| 2005 | $10.79B | -1.2% | ||
| 2004 | $10.92B | +11.8% | ||
| 2003 | $9.76B | +18.0% | ||
| 2002 | $8.27B | +16.5% | ||
| 2001 | $7.10B | +17.5% | ||
| 2000 | $6.05B | +20.6% | ||
| 1999 | $5.01B | +13.2% | ||
| 1998 | $4.43B | -4.6% | ||
| 1997 | $4.65B | -23.8% | ||
| 1996 | $6.10B | +12.3% | ||
| 1995 | $5.43B | +1.4% | ||
| 1994 | $5.36B | +17.2% | ||
| 1993 | $4.57B | -6.6% | ||
| 1992 | $4.89B | -1.5% | ||
| 1991 | $4.97B | +43.2% | ||
| 1990 | $3.47B | -7.7% | ||
| 1989 | $3.76B | +16.5% | ||
| 1988 | $3.23B | +6.0% | ||
| 1987 | $3.04B | +11.1% | ||
| 1986 | $2.74B | +14.7% | ||
| 1985 | $2.39B | — |
Net Assets values are taken from Eli Lilly's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Eli Lilly (LLY) most recent annual net assets stands at $26.54B (2025) – surged 87.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Eli Lilly net assets compounded at +36.3% per year, sustaining 6 straight years of year-over-year growth.
2025 marks the peak net assets at $26.54B, with the historical low of $2.39B recorded in 1985.
Among 8 Healthcare peers, Eli Lilly (LLY) ranks 7th; the peer median for net assets is $53.01B.
Eli Lilly Net Assets by Year
Eli Lilly Net Assets 2025: $26.54B
Eli Lilly net assets in 2025 was $26.54B, surged 87.0% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Net Assets 2024: $14.19B
Eli Lilly net assets in 2024 was $14.19B, surged 31.8% from 2023.
Eli Lilly Net Assets 2023: $10.77B
Eli Lilly net assets in 2023 was $10.77B, edged up 1.1% from 2022.
Eli Lilly Net Assets 2022: $10.65B
Eli Lilly net assets in 2022 was $10.65B, grew 18.6% from 2021.
Eli Lilly Net Assets 2021: $8.98B
Eli Lilly net assets in 2021 was $8.98B.
See more financial history for Eli Lilly (LLY).
Sector peers — Net Assets
Companies in the same sector as Eli Lilly, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $53.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Eli Lilly's net assets?
- Latest reported net assets for Eli Lilly (LLY) is $26.54B (period ending December 31, 2025).
How has Eli Lilly net assets changed year-over-year?
- Eli Lilly (LLY) net assets changed +87.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly net assets?
- Eli Lilly (LLY) net assets compound annual growth rate is +36.3% over the most recent 5 years available.
When did Eli Lilly net assets hit its highest annual value?
- Eli Lilly net assets reached its highest annual value of $26.54B in 2025.
What was Eli Lilly net assets in 2024?
- Eli Lilly (LLY) net assets in 2024 was $14.19B.
What was Eli Lilly net assets in 2025?
- Eli Lilly (LLY) net assets in 2025 was $26.54B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.